QDEL - QuidelOrtho Corporation
After hours:
Chart Events
Commodity Channel Index
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 85.65 |
| Open | 86.12 |
| Bid | 83.79 x 800 |
| Ask | 87.00 x 800 |
| Day's Range | 85.92 - 87.00 |
| 52 Week Range | 66.88 - 108.35 |
| Volume | |
| Avg. Volume | 360,914 |
| Market Cap | 5.741B |
| Beta (5Y Monthly) | 0.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.09 |
| Earnings Date | May 02, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 124.00 |
Fair Value
Related Research
Business WireQuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
SAN DIEGO, May 23, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the William Blair 43rd Annual Growth Stock Conference in Chicago, Illinois, on June 6, 2023.
- Thomson Reuters StreetEvents
Q1 2023 QuidelOrtho Corp Earnings Call
Q1 2023 QuidelOrtho Corp Earnings Call
Business WireQuidelOrtho Reports First Quarter 2023 Financial Results
SAN DIEGO, May 03, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the first quarter ended April 2, 2023.
Business WireQuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
SAN DIEGO, April 13, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023.
Business WireQuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
SAN DIEGO, March 28, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, celebrates Women’s History Month by announcing that the QuidelOrtho Women’s Leadership Network (QWLN) has been formed, creating an enhanced network with 14 global leaders supporting 16 chapters around the world.
Simply Wall St.QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 36% Below Their Intrinsic Value Estimate
Key Insights QuidelOrtho's estimated fair value is US$137 based on 2 Stage Free Cash Flow to Equity QuidelOrtho's...
Zacks3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
- Zacks
QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA Approval
QuidelOrtho's (QDEL) receipt of the FDA's De Novo approval is expected to enable it to provide the test as an aid in the diagnosis of SARS-CoV-2 infections in symptomatic individuals.
Business WireQuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
SAN DIEGO, March 08, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted a De Novo request from the U.S. Food and Drug Administration (FDA), allowing the company to market its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19 to be awarded F
Insider Monkey17 High Growth Low PE Stocks
In this article, we will take a look at the 17 high growth low PE stocks. To see more such companies, go directly to 5 High Growth Low PE Stocks. The optimism seen in financial markets during the start of 2023 is fading as retail sales data, CPI numbers and jobs report collectively dashed any […]
Insider Monkey13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According to a report by T.Rowe Price, healthcare stocks can be generally divided into two […]
Business WireQuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
SAN DIEGO, March 02, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference in Orlando, Florida, on March 7, 2023.
PR NewswireImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for Pharmacies
ImageMover, a provider of Workflow Services for pharmacies, is proud to announce its partnership with QuidelOrtho, a leading provider of point-of-care diagnostic testing solutions, to bring a comprehensive solution for pharmacist-administered testing for a variety of illnesses, including COVID-19, influenza A+B, Lyme disease, strep throat, and RSV. This revolutionary combination of diagnostic hardware and customized software offers patients fast and accurate results and simplifies the test-to-tr
- Simply Wall St.
QuidelOrtho Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag
QuidelOrtho ( NASDAQ:QDEL ) Full Year 2022 Results Key Financial Results Revenue: US$3.27b (up 92% from FY 2021). Net...
Insider Monkey12 High Growth Healthcare Stocks to Buy
In this article, we will take a look at the 12 high growth healthcare stocks to buy. To see more such companies, go directly to 5 High Growth Healthcare Stocks to Buy. The healthcare sector proved its mettle in 2022. When the broader stock market was in turmoil, major healthcare companies, including Cardinal Health, McKesson […]
- Simply Wall St.
QuidelOrtho Corporation Just Missed Revenue By 8.0%: Here's What Analysts Think Will Happen Next
It's been a good week for QuidelOrtho Corporation ( NASDAQ:QDEL ) shareholders, because the company has just released...
Insider MonkeyQuidelOrtho Corporation (NASDAQ:QDEL) Q4 2022 Earnings Call Transcript
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2022 Earnings Call Transcript February 15, 2023 Operator: Welcome to the QuidelOrtho Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast. At this time, all participant lines are in listen-only mode. For those of you participating on the conference call, there will be an opportunity for your questions […]
ZacksQuidelOrtho (QDEL) Q4 Earnings Top Estimates, Margins Down
QuidelOrtho (QDEL) reports robust overall top-line results in fourth-quarter 2022, despite disappointing segmental and geographical performances on a reported basis.
Business WireQuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
SAN DIEGO, February 15, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the fourth quarter ended January 1, 2023.
- Simply Wall St.
QuidelOrtho (NASDAQ:QDEL) pulls back 4.3% this week, but still delivers shareholders favorable 14% CAGR over 5 years
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
InvestopediaTop Healthcare Stocks
Top healthcare stocks include Azenta for best value, Neurocrine Biosciences for fastest growth, and Signify Health for most momentum.
Business WireQuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
SAN DIEGO, January 06, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary unaudited revenue results for the fourth quarter and full year ended January 1, 2023.
- Simply Wall St.
Is QuidelOrtho Corporation's (NASDAQ:QDEL) Latest Stock Performance A Reflection Of Its Financial Health?
QuidelOrtho (NASDAQ:QDEL) has had a great run on the share market with its stock up by a significant 19% over the last...
Business WireQuidelOrtho to Present at the J.P. Morgan Healthcare Conference
SAN DIEGO, December 28, 2022--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 9, 2023, with a presentation scheduled for 9:00 a.m. PST / 12:00 p.m. EST.
TipRanksBillionaire David Rubenstein Says Recession Is Likely, but Stays Heavily Invested in These 2 Stocks
The voices issuing warnings of an impending recession have been growing louder. The feeling on Wall Street is that one is all but inevitable right now. One prominent name to wade in on the matter is billionaire David Rubenstein. The Carlyle Group co-founder believes that due to the current economic environment of "jacked up" interest rates, gross domestic product growth is set to decelerate, bringing in to play a recession. Not only that, but he also thinks the Fed is unlikely to put the brakes